TP53 and neoplasm: A rat tumor model for PNETs developed by Eibl and Wiestler[8,9], using gene transfer of SV40LT to inactivate tumor suppressor genes including TP53, also triggered the detection of the first TP53 mutations in medulloblastoma biopsies by Eibl three decades ago[10] [Table 1].